SCHEMBL6772144

SCHEMBL6772144

COc1cccc(-n2nc(CC(C)CC(C)(C)C)c3c2CC(C)CC3=O)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 1/20 0.36
ABCG2 Q9UNQ0 6/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
CSNK2A1 P68400 1/20 0.34
CSNK2A3 Q8NEV1 1/20 0.34
HPGD P15428 1/20 0.34
SLC5A1 P13866 1/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
SRC P12931 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770636 0.90 RIPK2 (0.35) RIPK2SLC5A1RAB9ASMN1; SMN2PDE4A
SCHEMBL6770294 0.89 SRC (0.36) ABCG2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL6163003 0.87 ABCG2 (0.40) ABCG2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL6778055 0.85 SRC (0.43) RIPK2ABCG2CSNK2A2CSNK2BCSNK2A1
SCHEMBL6771525 0.83 OPRM1 (0.50) SRC
SCHEMBL6772625 0.82 CSNK2A2 (0.34) ABCG2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL6766537 0.81 ALDH1A1 (0.41) ABCG2HPGDSLC5A1RAB9ASMN1; SMN2
SCHEMBL6766708 0.81 RIPK2 (0.48) RIPK2HPGDRAB9ASMN1; SMN2SRC
SCHEMBL6775862 0.79 ABCG2 (0.39) ABCG2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL6772063 0.79 OPRM1 (0.48) RAB9ASMN1; SMN2SRCL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed